TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 2 | 1 | 2 | -1 | 9 | 73 | 12 | -20 | -41 | 5 |
| P | %wins | 50 | 100 | 100 | 100 | 0 | 0 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/19/23 19:52 | 9/19/23 | NMRA | Neumora Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T | P.d | 30,000 | 17.00 | 0 | 1,765 | 5 | 35,369 | D | |||||||||||||||
9/13/21 19:27 | 9/10/21 | BGNE | Beigene, Ltd. | DE | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T | P | 50,000 | 302.06 | 0 | 166 | 1 | 18,944 | D | |||||||||||||||
12/18/13 18:09 | 12/17/13 | TLOG | Tetralogic Pharmaceuticals Corp | DE | Health | Drug | Pharmaceutical Preparations | Amgen Inc | CA | T | P.d | 1,905 | 7.00 | 3 | 272 | 38 | 990 | M | 0 | -2 | 9 | 73 | 12 | -20 | -41 | ||||||||
3/7/12 20:41 | 3/6/12 | MITI | Micromet, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T | P.m | 322,340 | 11.00 | 21 | 29,304 | 41 | 100,635 | M | 39 | 105 | 151 | 69 | 34 | 0 | 0 | 0 | |||||||
3/6/12 19:53 | 3/2/12 | MITI | Micromet, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Amgen Inc | CA | T | P.m | 27,372 | 11.00 | 25 | 2,488 | 3 | 82,513 | I | 40 | 94 | 136 | 73 | 34 | 0 | 0 | 0 | 0 | ||||||
11/17/03 12:29 | 11/14/03 | TLRK | Tularik Inc | DE | Health | Drug | Pharmaceutical Preparations | Amgen Inc | CA | T | P | 17,289 | 11.90 | 0 | 1,453 | 12 | 13,953 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |